(redirected from Chronic Hepatitis B)
Also found in: Dictionary, Thesaurus, Medical.
Category filter:
CHBCamp Half-Blood
CHBChong Hing Bank (est. 1948; Hong Kong)
CHBChronic Hepatitis B
CHBChildren's Hospital Boston (Boston, MA)
CHBCheck and Branch
CHBBachelor of Surgery
CHBChampion Enterprises Inc. (stock symbol)
CHBChild Benefit
CHBComplete Heart Block
CHBCollegium Hungaricum Berlin (Hungarian cultural institute; Berlin, Germany)
CHBCustoms House Broker
CHBcongenital heart block
CHBCold Hard Bitch
CHBCerexhe-Heuseux-Beaufays (Belgian highway project)
CHBComputers in Human Behavior (journal)
CHBCentral Hawkes Bay (agricultural region in the North Island of New Zealand)
CHBCertified Hotel Broker
CHBCargo Handling Battalion
CHBCurly-Haired Boyfriend (nickname for Boston Globe sports columnist Dan Shaughnessy)
CHBClear Hold Build
CHBChristopher Hamilton Brashier (Lawrenceville, NJ investment group)
CHBCentre Hépato-Biliaire (French: Hepatobiliary Center)
CHBConcrete Hollow Blocks (construction)
CHBCentre Hospitalier de Blois (French: Blois Hospital Center; Blois, France)
CHBCombined Hormone Blockade (prostate cancer)
CHBCertified Head Bustas (gang)
CHBCornell Hurd Band
CHBContainer Handling Building (US government)
CHBCentre Hospitalier de Beauvais (French: Beauvais Hospital Center; Beauvais, France)
CHBClub Hippique des Bruyères (French: Bruyeres Equestrian Club; Bruyeres, France)
CHBClub Hippique de Bourbon (French equestrian club)
CHBCentre Hospitalier de Béziers (French: Béziers Hospital Center; Béziers, France)
CHBChurch House Bookshop (UK)
CHBCan't Hold Back
CHBCurly-Haired Bastard
CHBChapel Hill Brokers
CHBCenter Halfback (soccer)
CHBCentre Hospitalier de Bhannès (B'hannes Medical Center, Lebanon)
CHBCheck Hook Boxing (forum)
CHBCardiovascular Health Branch (US CDC)
CHBCommunity Hospital Bed
CHBChung Hwa Boatworks (Taiwan)
CHBCock's Head Brand (Chemical Company of Malaysia Berhad)
CHBCentre Hospitalier Bourg-en-Bresse (French: Bourg-en-Bresse Hospital Center; Bourg-en-Bresse, France)
CHBCamphill Boys Grammar School (UK)
CHBCentre Hospitalier de Bourges (French: Bourges Hospital Center; Bourges, France)
CHBCentre Henri Bénard (French: Henri Bénard Center; European Research Community on Flow, Turbulence and Combustion)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Chronic hepatitis B is usually defined by the presence of hepatitis B surface antigen in the blood or serum for longer than 6 months.
The projects will focus on partnerships to increase the identification of persons with chronic hepatitis B, increase health care provider awareness and their capacity to conduct hepatitis B screening and treatment, and improve multi-sector coordination and linkage to care for persons infected with hepatitis B.
Lamivudine was the first approved polymerase inhibitor for chronic hepatitis B. It is characterized by excellent tolerability with minimal or no side effects [2, 13].
When considering the chronic progress characteristics throughout several decades of hepatitis B, the promotion of patient's self-management ability of chronic hepatitis B is very important.
The treatment of chronic hepatitis B aims to prevent or reduce the development of liver cirrhosis and hepatocellular carcinoma, and also aims to suppress viral replication, normalize ALT levels, decrease liver damage, and obtain HBsAg seroconversion.
(37-43) The presence of steatosis is significantly more common in patients with chronic hepatitis C than in patients with either chronic hepatitis B or autoimmune hepatitis.
Thus, even as the global hepatitis B immunization program continues to reduce new cases of hepatitis B infection and the enormous burden of chronic hepatitis B disease, it is simultaneously generating VEMs, thereby potentially sewing the seeds of the program's failure.
One hundered Chronic Hepatitis B patients diagnosed by Polymerase Chain Reaction were matched with 100 healthy persons, served as control, were selected for total and free thyroid hormones using ELISA, while serum proteins were estimated spectrophotometrically.
(NASDAQ:IDIX), Cambridge, Mass, has announced that the Swissmedic has approved telbivudine as a new treatment for chronic hepatitis B (CHB) in compensated patients with evidence of viral replication and active liver inflammation.
-- The Food and Drug Administration has approved a new drug, entecavir, for the treatment of chronic hepatitis B infection in adults.
The CDC estimates about 15% of all Americans with chronic hepatitis B virus and 39% with hepatitis C infections were released from correctional facilities in 2002.
Full browser ?